ARTICLE 1Exclusive Licensing Agreement • November 21st, 2005 • Zann Corp • Pharmaceutical preparations
Exhibit 10.4 EXCLUSIVE LICENSING AGREEMENT BETWEEN: INSTITUTE OF MATERIA MEDICA Chinese Academy of Medical Sciences & Peking Union Medical College 1 Xian Nong Tan Street, Beijing 100050, China AND: BEIJING UNION PHARMACEUTICAL FACTORY 1 Xian Nong Tan...Exclusive Licensing Agreement • September 12th, 2006 • Sinopharm Inc • Pharmaceutical preparations
EXHIBIT 10.19 EXCLUSIVE LICENSING AGREEMENT This Agreement made effective as of this 24th day of June, 1999, by and between Ingen Technologies, Inc., a Nevada Corporation doing business in the State of California, further referred as the ("Company")...Exclusive Licensing Agreement • March 3rd, 2008 • Ingen Technologies, Inc. • Miscellaneous manufacturing industries • California
Exclusive licensing agreementExclusive Licensing Agreement • July 22nd, 2020 • England and Wales
Gaming of Ground Floor, 15 Heritage Park, Hayes Way, Cannock, Staffs, WS11 7LT and the “Assignor” (Full name as provided in your Submission Form), that states:
LONGPORT, INC. 791 S. CHESTER ROAD SWARTHMORE, PA 19081Exclusive Licensing Agreement • May 11th, 1998 • Longport Inc • Wholesale-medical, dental & hospital equipment & supplies
DURATION: THREE YEARS: 180 DAY INTERVALS, THE AGREEMENT CAN BE CANCELLED BY EITHER PARTY. *RENEWABLE AFTER THREE YEARS FOR SAME AMOUNT. *CHANGES AGREEABLE WITH BOTH PARTIES *CANCELLATION FOR JUST CAUSE GIVEN BY SIXTY (60) DAYS WRITTEN NOTICE. NOTIFICATION BY CERTIFIED OR REGISTERED MAIL.
Exclusive Licensing Agreement between The University of Washington and Lumera Corporation Effectively Dated October 16, 2000 List of ExhibitsExclusive Licensing Agreement • April 2nd, 2001 • Microvision Inc • Electronic components, nec • Washington
This Exclusive Licensing Agreement is entered into by and between the University of Washington (the “University”) and Lumera, Inc., a Washington corporation (the “Licensee”) as of the Effective Date, subject to the following terms and conditions.
Exclusive Licensing Agreement with Meitu NetworksExclusive Licensing Agreement • September 2nd, 2014
This announcement is made by Feiyu Technology International Company Ltd. (the “Company”, together with its subsidiaries, the “Group”) pursuant to the Rule 13.09(2) of the Rules (the “Listing Rules”) Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).
First Addendum Exclusive Licensing AgreementExclusive Licensing Agreement • February 26th, 2019 • RedHill Biopharma Ltd. • Pharmaceutical preparations
This First Addendum to the Agreement (as defined below) is made and entered into between Licensor and Licensee as of the Effective Date of the Agreement.
EXCLUSIVE LICENSING AGREEMENTExclusive Licensing Agreement • December 14th, 2020 • California
This Exclusive Licensing Agreement (“Agreement”) is by and between LDRLY (Technologies) Inc, a corporation formed under the laws of the Province of British Columbia, with a principal place of business at 104 Front Street, Nanaimo, BC V9R 5H7, Canada (“LDRLY”), and CHEECH & CHONG, LLC
EXCLUSIVE LICENSING AGREEMENT FOR BONFIGLIOLI TO MANUFACTURE AND SELL CVTCORP mCVT PATENTED TECHNOLOGYExclusive Licensing Agreement • October 9th, 2018
CVTCORP, a world leader in the design and development of revolutionary, high-efficiency mechanical Continuously Variable Transmissions (mCVT) for the off-highway market, and Bonfiglioli, a worldwide designer, manufacturer and distributor of a complete range of geared motors, drive systems, planetary gearboxes and inverters, announced they have entered into an exclusive licensing agreement for Bonfiglioli to manufacture and sell the CVTCORP mCVT patented technology for telehandlers and other equipment. The cooperation between Bonfiglioli and CVTCORP will also include developing a full line of transmissions based on the currently available mCVT.
Exclusive Licensing Agreement for “SONG NAME” DATE: NO DATEExclusive Licensing Agreement • February 24th, 2022 • Ontario
Kurate Music Ltd (“Label”) on behalf of its administered channel “Kurate Music is delighted to have this opportunity to work with Artist Name p/k/a: “performer name” collectively (“Artist”) to distribute and exploit certain sound recordings and audiovisual works owned or controlled by Artist as further detailed herein.
AMENDED AND RESTATED SUPPLY, DEVELOPMENT & EXCLUSIVE LICENSING AGREEMENTExclusive Licensing Agreement • February 29th, 2016 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New York
This AMENDED AND RESTATED SUPPLY, DEVELOPMENT & EXCLUSIVE LICENSING AGREEMENT (the “Agreement”), effective as of October 30, 2015 (the “Effective Date”), is made and entered into by and between Insys Therapeutics, Inc., a Delaware corporation having its principal place of business at 1333 S. Spectrum Blvd., Suite 100, Chandler, AZ 85286 (hereinafter called “PURCHASER”) and Aptargroup, Inc., a Delaware corporation having its principal place of business at 475 West Terra Cotta, Suite E, Crystal Lake, IL, 60014-9695 (hereinafter called “SELLER”). PURCHASER and SELLER being hereinafter called individually the “Party” and collectively the “Parties”.
Exclusive Licensing Agreement LetterExclusive Licensing Agreement • March 2nd, 2009 • Constant Environment, Inc. • Ontario
Constant Environment, Inc. With Head Office at: 1310 Contour Drive, Mississauga, Ontario. Canada. L5H 1B2 (Hereafter referred to as LICENSEE)
EXCLUSIVE LICENSING AGREEMENT FOR IN-HOUSE DEVELOPED MONOCLONAL ANTIBODY FARLETUZUMAB IN LATIN AMERICA CONCLUDED WITH EUROFARMA LABORATÓRIOS S.A.Exclusive Licensing Agreement • September 9th, 2021
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its research subsidiary Morphotek, Inc. (Headquarters: Pennsylvania, United States, President and CEO: Nicholas Nicolaides, “Morphotek”) has signed an exclusive licensing agreement with Eurofarma Laboratórios S.A. (Headquarters: São Paulo, Brazil, President: Maurizio Billi, “Eurofarma”) to develop and commercialize the monoclonal antibody farletuzumab (development code: MORAb-003) as a potential anticancer agent in Latin America.
EUROPA GLOBAL, INC. EXCLUSIVE LICENSING AGREEMENT This exclusive licensing agreement ("Agreement") dated the 12th day of December, 2000 by and between Europa Global, Inc. (EGI), a Colorado corporation whose address is 102 S. Tejon Street, Suite 1100,...Exclusive Licensing Agreement • February 25th, 2002 • Maximum Dynamics Inc • Colorado
Exhibit 10.32 Exclusive Licensing Agreement ----------------------------- Whereas Longport, Inc. is the owner of the patent rights to a new medical technology which Longport calls the "soft tissue diagnostic scanner," developed in part by Dr. Mary...Exclusive Licensing Agreement • May 11th, 1998 • Longport Inc • Wholesale-medical, dental & hospital equipment & supplies
Translated from Chinese The Exclusive Licensing Agreement for Harbin Renhuang Pharmaceutical Co., Ltd. to Use Forest Resources under Yichun Red Star Forestry BureauExclusive Licensing Agreement • January 30th, 2012 • China Botanic Pharmaceutical • Pharmaceutical preparations
The exclusive licensing agreement to use forest resources under Yichun Red Star Forestry Bureau was signed by the following parties on January 11, 2011:
Exhibit 10.2 EXCLUSIVE LICENSING AGREEMENT This Exclusive Licensing Agreement ("Agreement") is made as of July 12, 2005 by and between Biowell Technology Inc., a company duly incorporated and organized under the laws of Taiwan, Republic of China...Exclusive Licensing Agreement • July 21st, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • Nevada
AMENDMENT NUMBER ONE TO THE AMENDED AND RESTATED SUPPLY, DEVELOPMENT & EXCLUSIVE LICENSING AGREEMENTExclusive Licensing Agreement • August 7th, 2017 • Insys Therapeutics, Inc. • Pharmaceutical preparations
THIS AMENDMENT NUMBER ONE (“Amendment Number 1”) to the AMENDED AND RESTATED SUPPLY, DEVELOPMENT & EXCLUSIVE LICENSING AGREEMENT with an effective date of October 30, 2015 (the “A&R Agreement”), is hereby entered into as of April 6, 2017 with an effective date of January 1, 2017 (“Effective Date”), by and between INSYS MANUFACTURING, LLC, a Texas limited liability company, having its place of business at 1333 S. Spectrum Blvd., Suite 100, Chandler, AZ 85286 (“PURCHASER”) and APTARGROUP, INC., a Delaware corporation, having its place of business at 475 West Terra Cotta Avenue, Suite E, Crystal Lake, IL 60014-9695 (“SELLER”).
EXHIBIT 10.16 EXCLUSIVE LICENSING AGREEMENT This Exclusive Licensing Agreement ("Agreement") is effective as of June 1, 2002, between Terra Block, Inc., a Florida corporation, with its principal place of business at 2875 S. Orange Avenue, Suite...Exclusive Licensing Agreement • March 3rd, 2003 • L L Brown International Inc • Services-educational services • Florida
EXCLUSIVE LICENSING AGREEMENTExclusive Licensing Agreement • July 14th, 2005 • Remedent, Inc. • Dental equipment & supplies • Nevada
NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the mutual covenants and agreements contained in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the parties, the parties hereby agree as follows:
AMENDMENT TO EXCLUSIVE LICENSING AGREEMENT Extension of Trial PeriodExclusive Licensing Agreement • September 10th, 2007 • CleanTech Biofuels, Inc.
This Agreement is made January l1th, 2006 by and between Brelsford Engineering, a Montana corporation, whose operating office is located at 8655 Bridger Canyon Road, Bozeman, MT 59715 (hereinafter the “LICENSOR”) and SRS Energy, Inc., a Delaware corporation, whose operating office is located at 7320 Forsyth, Unit 102, St. Louis, MO 63105 (hereinafter the “LICENSEE”).
RECITALSExclusive Licensing Agreement • November 30th, 2005 • Ingen Technologies, Inc. • Blank checks • California
EXCLUSIVE LICENSING AGREEMENT This Exclusive Licensing Agreement ("Agreement") is made as of this Fourteenth (14th) day of September, 1999, by and between: BIOREMEDIAL TECHNOLOGIES, INC., a Pennsylvania corporation, with its principal office located...Exclusive Licensing Agreement • February 25th, 2000 • Infectech Inc • Services-commercial physical & biological research • Pennsylvania
EXCLUSIVE LICENSING AGREEMENTExclusive Licensing Agreement • May 12th, 2004 • International Sports & Media Group Inc • Periodicals: publishing or publishing & printing • California
This AGREEMENT (Licensing Agreement) is made this 5th day of February, 2004 by and between THE ALL AMERICAN BURGER, HAIG INTERNATIONAL, INC., a corporation incorporated under the laws of the State of California and having a business address at 2821 Dumfries Road, Los Angeles, CA 90064 (hereinafter referred to as LICENSOR), and GLOBAL HOSPITALITY GROUP INC , a corporation incorporated under the laws of the State of NEVADA, and having a business address at MISSION BLVD SUITE 290, SAN DIEGO, CA 92109 (hereinafter referred to as " LICENSEE"):
EXCLUSIVE LICENSING AGREEMENTExclusive Licensing Agreement • August 22nd, 2020 • Georgia
The following agreement (“Agreement”) is hereby made and entered into as of _ (the “Effective Date”) by and between Sticks & Hitz, L.L.C., with a mailing address of 1109 Boll Weevil Circle Suite 8 PMB # 176, Enterprise, Alabama 36330, USA (“Producer”), and the following individual and/or entity (individually and collectively, “Artist”):
EXCLUSIVE LICENSING AGREEMENT between The University of Washington and Lumera Corporation Effectively Dated October 20, 2000Exclusive Licensing Agreement • May 19th, 2004 • Lumera Corp • Washington
This Exclusive Licensing Agreement is entered into by and between the University of Washington (the “University”) and Lumera, Inc., a Washington corporation (the “Licensee”) as of the Effective Date, subject to the following terms and conditions.
EXHIBIT B EXCLUSIVE LICENSING AGREEMENTExclusive Licensing Agreement • January 5th, 2011 • Immunotech Laboratories, Inc. • Services-motion picture & video tape production
This EXCLUSIVE LICENSING AGREEMENT (“Agreement”), effective as of September 1, 2008 (the “Effective Date”), is entered into by and among DANIEL ZHABILOV as Trustee of The Zhabilov Trust, a California Trust executed at Los Angeles, California on March 2, 2006 (“The Zhabilov Trust”) and IMMUNOTECH LABORATORIES, INC., a California corporation (“Immunotech”), with its principal offices located at ….
